Top 50 Biotechnology Startup Investors in Sweden (June 2026)

Portfolio highlights

• Capitainer — Capitainer enables patients to collect their own volume-defined dried blood spot at home.Capitainer started in 2016. Their technology is a volumetric blood collection device that enables patients to conveniently and safely collect blood samples in the comfort of their own home, our technology is more accurate than today’s solutions. Capitaineroffers impressive cost and environmental savings for healthcare providers managing millions of conventional blood samples annually.
• SAGA Diagnostics — SAGA Diagnostics AB is a personalized cancer diagnostics and disease monitoring company focused on molecular genetic analyses of a powerful cancer biomarker: circulating tumor DNA (ctDNA). The company was founded in 2016 as a spin-out from a highly successful research group at Lund University, with a mission to improve precision cancer medicine,provide more accurate treatment monitoring, and improve patient survival using minimally-invasive liquid biopsy cancer testing services and kits.The SAGA team consists of renowned scientists, highly qualified staff and an experienced management team who work together to launch SAGA’s ultrasensitive services and products as part of the ongoing revolution in cancer research, drug development, and clinical diagnostics. SAGA’s proprietary tests can help patients, oncologists, and drug developers detect actionable mutations, stratify patient groups, and monitor treatment response, residual disease, and disease recurrence at an unprecedented sensitivity.
• Single Technologies — Founded in Stockholm, Sweden, with its long tradition in fiber optics, ultra-sensitive fluorescence spectroscopy and DNA sequencing, SINGLE’s ambition is to become the instigator of 3-D Sequencing.

Portfolio highlights

• Embedl AB — Efficient Deep Learning by Deep Learning model optimization
• Repli5 — Enabling autonomous vehicles with synthetic data. We automate the creation of synthetic data and digital twins.
• Detecht — Looking for a motorcycle app for your upcoming trips? Download Detecht with built-in GPS, Navigation, Route suggestions and Crash Detection on App Store or Google Play Store

Portfolio highlights

• Novatron — A new fusion reactor design for stable plasma confinement and fusion power generation.
• Open Payments — Open Payments connects you to multiple banks through one single unified API. This removes the complexity and frictions of many diverse integrations
• Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.

Portfolio highlights

• Indevex AB — Indevex is a science-based and privately owned biotech company from Sweden. A natural and reliable partner, providing evidence based natural nutrition concepts based on the patented NGC™ Formula.
• Xaga Surgical — Xaga Surgical aims to minimize the risk of infections by inventing safer medical needles.
• Inhalation Sciences — The PreciseInhale patented aerosol generation R&D platform delivers respirable dry powder aerosols from preclinical cell studies all the way through to human clinical trials, significantly accelerating drug development timelines. The platform’s one-animal-at-a-time system requires just milligrams, not grams of costly test substance for a fullPK study and delivers high-resolution lung data of, typically, <10% SD. We carry out Contract Research for novel and generic inhalation drug developers, toxicology and environmental research institutes and university research institutes in the inhalation and aerosolization field.

Portfolio highlights

• Epigenica — Epigenica focuses on advancing epigenomics through its EpiFinder™ platform, a multiplexed ChIP-seq technology for high-throughput analysis of epigenetic marks. The company offers R&D services for the development of therapeutic molecules and diagnostic methods using epigenetics. Epigenica aims to improve scientists' ability to capture andextract insights from the epigenome, contributing to precision medicine and the discovery of new biomarkers.
• IntuiCell — IntuiCell develops a fundamentally new recursive computing architecture and associated technology platform.
• ProteomEdge — The objective of ProteomEdge is to use mass spectrometry to provide an analytical platform with cutting-edge precision for absolute protein quantification.

Portfolio highlights

• Orbis Medicines — Orbis Medicines is a novel macrocyclic chemistry and computational platform for high-throughput drug discovery.
• Nkarta Therapeutics — Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies.While T-cell therapy, often known as CAR-T, has proven successful in certain cancer indications, its promise has been limited toa few hematologic malignancies and the side effects can be severe. Natural Killer cells are the immune system’s first responders against diseases and pathogens. Unlike T cells, they have an inherent ability to target tumor cells without genetic alteration, and therefore hold significant promise in the development of potent therapies that can be used more readily for diverse tumor types. Nkarta’s differentiated cell therapy approach is designed to boost and enhance the inherent power of Natural Killer cells to target and destroy tumor cells, while also offering a better tolerated safety profile.
• Tobira Therapeutics — Tobira Therapeutics, Inc., a biotechnology company, engages in the research, discovery, acquisition, development, and commercialization of antiviral compounds for the treatment of life-threatening and life-altering infectious diseases. It develops TBR-652 and TBR-220 antagonists for the treatment of HIV/AIDS, hepatitis, and other associatedinfectious conditions. The company was founded in 2006 and is based in Princeton, New Jersey.

Portfolio highlights

• ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
• HelloBetter — HelloBetter (hellobetter.de) was founded in 2015 under the name GET.ON Institut für Online Gesundheitstrainings GmbH (geton-institut.de) by internationally renowned research psychologists, and in close partnership with one of the largest public health care insurance companies in Germany (BARMER). HelloBetter is a pioneer in the field of e-mentalhealth and a leading provider of online mental health courses. Its work has a strong scientific basis – the courses were developed, evaluated, and implemented in a practice setting, and their effectiveness has been proven in 33 randomized controlled trials according to the highest standards of scientific practice. HelloBetter offers the widest range of evidence-based online mental health courses worldwide, with 11 digital courses covering 8 problem areas (stress, depression, insomnia, depression in the case of chronic illness, chronic pain, alcohol consumption, excessive worry, and panic and anxiety).In October 2021, the digital therapeutic 'HelloBetter Stress and Burnout' has been permanently approved by the German Federal Institute for Drugs and Medical Devices (BfArM) as a Digital Health Application (DiGA) and thus is available by prescription free of charge for more than 50 million adults. It is the world’s first and so far only prescription digital therapeutic for the treatment of burnout symptoms.Through diverse cooperations with national and international research groups (including FAU Erlangen, University of Ulm, VU Amsterdam, and Harvard University) HelloBetter finds practical applications for the latest research innovations. Our products and our team have been awarded numerous national and international prizes. These include the Novartis & Sandoz/Hexal Digital Health Prize 2018, the Comenius Award of the European Federation of Psychologists’ Association, and the Good Practice in Mental Health & Wellbeing seal of approval as part of the EU Compass 2018, which recognises high-quality mental health initiatives in Europe in order to guide health care providers to effective and proven services.
• Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.

Portfolio highlights

• Sunsave — Save money on your bills and gain energy independence with Sunsave solar panel and battery solutions. Get a free quote today.
• Ankar AI — Your AI Operating System for Patents
• Sava Technology — SAVA is reinventing health monitoring with a novel biosensing platform enabling real-time, affordable, and painless molecular monitoring.

Portfolio highlights

• PharmNovo — Latest News from PharmNovo. Learn more about pain, neuropathic pain, chronic pain. Treatment with our lead candidate PN6047. Therapy market, our networks. There is a huge unmet medical need for people suffering from chronic pain.
• BOOST Pharma — Boost Pharma: Developing a stem cell therapy for Osteogenesis Imperfecta.
• Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.

Portfolio highlights

• Omocom — Omocom offers safe, simple and secure insurance for all kind of renting, sharing and re-using, digitally, automated and integrated into the sales flow of the platform
• Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
• Blueprint Genetics — We offer complete genetic testing and genetic diagnostics to medical professionals worldwide. Learn more about our winning clinical-grade NGS offering!

Portfolio highlights

• Quanscient — We are building next generation simulation software-as-a-service utilizing Quantum computing algorithms. Our specialty domain of simulations is Computational Electromagnetics.
• Hemi Health — Hemi Health is a Danish digital-first headache and migraine clinic specializing in diagnosis, personalized treatment, and care for headaches using technology like an app for symptom tracking and video consultations.
• Porcelain Fortress — Porcelain Fortress was founded by a small band of romantics in the summer of 2016 in Reykjavik, Iceland.

Portfolio highlights

• Senseworks — Senseworks is an insight platform that enables colleagues to collaborate effectively with customers by providing a single source of truth for accounting data.
• Cold River Games — Crystalfall is an upcoming free online action RPG with customizable skills and an endless endgame, set in a steampunk world.
• Remos Space Systems — Remos Space Systems simplifies satellite ground operations.

Portfolio highlights

• Tavion — Tavion is a developer of battery energy storage systems that is expediting Europe's shift to renewable energy. Tavion creates and runs utility-scale BESS infrastructure to improve grid flexibility, stabilize intermittent renewable power, and promote energy independence in European markets.
• Serviceform — Welcome to future of communication - the truly all-in-one conversion and management software built for established businesses. Start now!
• Techarena — Since 2014 Techarena is the platform for innovation and Tech in the Nordics. From supporting startups and scaleups to bringing the Tech and Business world together at Scandinavia's Biggest Events.

Portfolio highlights

• MVision AI — AI-powered solutions that automate repetitive tasks, enable efficient radiotherapy workflows, and promote consistency across clinical processes.
• Quantrol Ox — Building Machine Learning Based Software for Quantum Control with a goal to maximise quantum computer uptime.
• Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.

Portfolio highlights

• Rivia — Integrated Clinical Trial Intelligence. Drive therapeutic evaluation and trial management with real-time insights.
• io Health — Io Health Technologies LLC provides AI-driven tools for home health documentation and workflow automation in healthcare.
• Sober Sidekick — Gamified peer to peer support

Portfolio highlights

• Plasmacure — Plasmacure develops innovative plasma technology for wound care. Discover how cold plasma is transforming the treatment of chronic wounds.
• Mirantus Health — Mirantus is building a distributed healthcare provider to improve access to care for underserved patients. Through healthcare services (Mirantus Care) and cloud-solutions (Mirantus OS), Mirantus empowers doctors to efficiently treat patients who were difficult to reach before. This improves healthcare access for patients, allows physicians to earnmore, while saving payors billions in downstream costs. Mirantus is on a mission to get every specialist physician in Europe to participate in distributed healthcare, to improve healthcare access for 100M+ underserved patients.
• Alba Health — Discover your baby's gut health & microbiome for the best start in life.

Portfolio highlights

• AIATELLA — Automating medical image analysis
• CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
• SampleFacts — Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection.

Portfolio highlights

• Bionamic — Bionamic provides solutions for the analysis of life science data to reduce or eliminate the manual steps between raw data and results.
• Parlametric — Parlametric is a research-based company that specializes in analytics, business intelligence, and market research services.
• Trackpaw Scientific — Contributing to the development of safe and effective pharmaceuticals at increased speed and quality by digitalising the preclinical study landscape.

Portfolio highlights

• Leetify — We help gamers identify their weaknesses, work on those weaknesses and track their progression.
• Mavenoid — Mavenoid is the only product support automation platform built for complex products and devices. Using our unique AI, we solve problems too complex for chatbots
• Antler — Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!

Portfolio highlights

• Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
• Navinci Diagnostics — Navinci is a Swedish biotech company specializing in innovative in situ proximity ligation assay-based solutions for spatial proteomics.
• Signifier Medical Technologies — Driving Innovation in the Sleep Market Signifier Medical Technologies (SMT) is a medical technology company focused on the development and commercialisation of innovative and non-invasive solutions for patients with sleep-disordered breathing conditions and snoring. Pioneers in challenging the wisdom of conventional sleep apnoea and snoring treatments, we've created the first daytime therapy that tackles the root cause of sleep-disordered breathing by physiologically retraining the airway against collapse.

Portfolio highlights

• Stendorren Fastigheter — Stendorren Fastigheter is a company involved in the real estate industry. It develops, owns, operates, and maintains industrial, logistical, and warehouse facilities. The business offers adequate and suitable space on fair lease terms through its tenant.
• pixlbio (formerly Phenaros) — Data-centric drug discovery with AI, Phenomics and Automation.
• Swedish Logistic Property — Swedish Logistic Property (SLP) specializes in the development and management of logistics properties across Sweden. With a focus on energy efficiency, SLP provides modern logistics solutions tailored to meet the needs of various businesses. The company's portfolio includes strategically located properties designed to support efficientlogistics and supply chain operations. SLP also engages in the acquisition and development of new properties, aiming to expand its footprint in the logistics real estate market. The company's commitment to sustainability is evident in its construction practices and the operation of its logistics facilities.

Portfolio highlights

• Apica — The Operational Data Fabric from Apica unifies and connects all your data using a revolutionary Active Observability architecture.
• MobileTag — Mobile Tag, the European leader in mobile barcode solutions, continues to innovate with the launch of its latest application: mobiletag Universal Reader and shopping.Mobile Tag is behind the creation of the flashcode, the standard 2D barcode used by operators in France. This type of Datamatrix barcode is used by the biggest companies indisplay, transportation, distribution, the pharmaceutical industry, and more.Mobile Tag has always tried to develop new technology from the consumer's point of view, and the mobiletag Universal Reader & shopping is no exception.The concept behind this application is to send, receive and share information and best prices to everyone and for everyone through all standardized barcodes.Scanning a barcode with your mobile phone is simply taking a picture of it with your phone, using the mobiletag application. Mobile tag is free!
• CorPower Ocean — CorPower Ocean AB was founded in 2009 to develop high efficiency Wave Energy Converters (WECs).CorPower's Wave Energy Converters deliver five times higher annual energy output per ton of device compared to previously known wave power solutions. The step-change improvement in performance and efficiency allows a Cost-of-Energy that cancompete with offshore wind. The products are currently in pilot with Iberdrola. CorPower has assembled a team with extensive experience in energy generation, design and manufacturing of production equipment, system engineering as well as the market expertise to allow us to continue transforming the technology of tomorrow into renewable energy applications of today.

Portfolio highlights

• Perfood — Perfood is a digital therapeutic startup that identifies what actions need to take on a personalized level, to prevent or fight diseases. Using sensors, lab results, and holistic analyses, they derive therapeutic angles and deliver them in a slick, easy-to-use way, making them accessible for all patients. They call this approach digitaltherapeutics. A digital solution that is just as effective as a drug. But without side effects.
• Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
• Rinri Therapeutics — Rinri Therapeutics has been founded on pioneering research into auditory stem cells led by Professor Marcelo Rivolta at the University of Sheffield.

Portfolio highlights

• AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
• Nanologica — Nanologica combines unique know-how in the field of materials technology with a genuine interest in solving real problems in life science. The company works with nanoporous silica which has properties that are attractive in a wide variety of applications. In order to succeed, development work is carried out in close dialog with customers.Nanologica is unique in that it is a world leader in controlling the form, type of porosity and surface area of particles of silica. This competence can be used to produce particles that have the potential to solve problems in diverse application areas. The company’s core competency has been developed and expanded in twoareas of application in particular: drug delivery on the one hand and on the other chromatography, a technology used for the separation and purification of products on the market and in development.The starting point for Nanologica’s work is the material sciences, a field in which the company’s founder has developed and patented completely new materials. The initial research was based at Stockholm University and the Ångström laboratories atUppsala University.
• KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.

Portfolio highlights

• Bionamic — Bionamic provides solutions for the analysis of life science data to reduce or eliminate the manual steps between raw data and results.
• Trackpaw Scientific — Contributing to the development of safe and effective pharmaceuticals at increased speed and quality by digitalising the preclinical study landscape.

Portfolio highlights

• Henlez — Henlez is a Danish startup company.
• Synklino — Synklino is a developer of a CMV-specific immunotoxin intended to eradicate the cytomegalovirus infection. The company's immunotoxin is highly effective, potent and fast-acting that kills lytic and latently infected cells, enabling patients to have long-term health benefits for transplantation.
• Galecto — Damora Therapeutics is working to fundamentally redefine care for people with blood disorders by bringing forward optimized therapies that dramatically improve patient outcomes.

Portfolio highlights

• Gesynta Pharma — Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
• Emergence Therapeutics — Emergence Therapeutics is a European biopharmaceutical company developing novel antibody-drug conjugates (ADC) to treat high-need cancers. Its lead program combines a highly specific antibody with optimized linker and payload technology to target Nectin-4 – an important target for a broad range of cancers which has been clinically validated as anADC target by enfortumab vedotin, now approved for the treatment of urothelial cancers by the US Food and Drug Administration. Emergence is also actively exploring opportunities to develop further first- or best-in-class ADCs driven by therapeutic need.
• TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.

Portfolio highlights

• Cellfion — Cellfion provides sustainable materials for next level clean energy storage and conversion devices.​
• Sonicflora — Plants have always been speaking. We can now understand them.
• Polar Light Technologies — Polar Light Technologies focuses on developing the next generation of Nano and micro LED technology.

Portfolio highlights

• Bionamic — Bionamic provides solutions for the analysis of life science data to reduce or eliminate the manual steps between raw data and results.
• Bluwhale — Unlock Web3 Wallet Potential with AI Insights. Supercharge Your Business Growth
• IntuiCell — IntuiCell develops a fundamentally new recursive computing architecture and associated technology platform.

Portfolio highlights

• CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
• AAX Biotech — AAX Biotech specializes in next-generation antibody therapeutics through our two unique and proprietary technologies, Seqitope™ and Opti-mAb™, that enable high-resolution and high throughput epitope mapping as well as stabilization of single chain variable fragments (scFv) for applications such as bispecific antibodies and CAR-T cells. OurTechnologies: Seqitope™ is a high-resolution, high throughput method for antibody epitope mapping that accelerates the development of efficacious therapeutics.Opti-mAb™ is a new scFv format with dramatically improved expression levels and reduced aggregation tendencies. This will significantly improve the next generation of cutting-edge immunotherapies such as CAR-T and bispecific antibodies.
• SampleFacts — Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection.

Portfolio highlights

• Metsera — Metsera operates as a clinical-stage biopharmaceutical company.
• EGenesis — At eGenesis, we envision a world where transplantation is accessible to all. We develop safe and effective human-compatible organs for transplantation.
• Protillion Biosciences — Protillion Biosciences is a biotech company commercializing disruptive technology for therapeutic antibody and drug discovery and accelerating biologic research and development productivity.

Portfolio highlights

• F2G — F2G is a biopharmaceutical company developing novel therapies for life-threatening fungal infections.
• Noema Pharma — DRIVING BETTER OUTCOMES Advancing therapeutics designed to deliver superior clinical benefit across both orphan and broader neurology indications Who we are ...
• Orbis Medicines — Orbis Medicines is a novel macrocyclic chemistry and computational platform for high-throughput drug discovery.

Portfolio highlights

• Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.
• Valar Labs — AI to Make Oncologists Smarter
• Imaginecare — Imaginecare is a self-care support that helps patients with long-term health challenges to a better life. Imaginecare consists of a technical platform supplemented with a range of services and analysis tools that together offer a complete solution for healthcare.

Portfolio highlights

• AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
• Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
• Prexton Therapeutics — Voici la page d'accueil du site web

Portfolio highlights

• Bounce Insights — Bounce Insights is a digital consumer research platform. It provides a direct link between brands and any consumer they needed to speak to by maintaining a community of active, engaged respondents on their mobile app.
• Adama Innovations — Adama Innovations have a disruptive technology for advanced manufacturing. The company have developed a simple process for creating patterns, on a scale invisible to the human eye, on ultra-hard materials.The micro patterns can be applied to injection molds and forming dies used for the fabrication of medical devices, improving theircapability and reducing the cost of manufacture. Other applications include labelling and anti-counterfeiting technology.The company's first product is a nano-scale probe fabricated in diamond, for metrology applications in high-tech manufacturing.The company is a spin-out from CRANN, the flagship nanotechnology institute in Trinity College Dublin.
• SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.

Portfolio highlights

• MeliBio — Discover MeliBio's innovative bee-free honey, promoting a sustainable future for humans and bees. Explore our mission, vision, and impact.
• Evo Foods — EVO foods is creating India’s first 100% plant based liquid egg
• Cultured Decadence — Growing real meat directly from animal cells.

Portfolio highlights

• Orthox Ltd. — Founded to commercialise technology developed at Oxford University, Orthox aims to revolutionise the way cartilage injuries are treated. Trauma and erosion of the smooth, stiff cartilage in our joints leads to Osteoarthritis (OA) a debilitating disease, which affects over 300 million patients globally and costs the US economy alone over $128billion each year. Current therapies to repair damaged cartilage focus either on tissue regeneration or on functional replacement; Orthox’s exceptionally strong, resilient, regenerative hydrogel technology, FibroFix™ achieves both these goals, offering a unique solution for the millions of patients suffering from damage to their joints. Initially targeting the knee, Orthox has developed a compelling set of data on lead product FibroFix™ Cartilage which has secured major awards from multiple funding bodies and will shortly enter clinical trials. FibroFix™ technology will then be rolled out to treat other joints and Orthox also has pipeline developments beyond orthopaedics in which strength and tissue regeneration are key. Pipeline expansion is valuable as growth in the annual global biomaterials market will exceed $250 billion by 2025. Orthopaedic biomaterials will form the largest proportion of this and natural biomaterials, like FibroFix™, will be the fastest growing market segment. Orthox: Reducing Pain, Increasing Mobility, Regenerating Strength™.
• Gedea Biotech — Gedea Biotech develops an antibiotic-free, safe and effective treatment of vaginal fungal infections. Vaginal yeast infections are a major problem that affects about 75% of all women at some point in life. Gedea Biotech's substance, GA101, is a natural substance that has always been part of their environment. It acts by lowering the pH as wellas providing a physical barrier protection and inhibiting biofilm formation. The first product will be a topical treatment of vaginal fungal infections.
• Oxford Endovascular — Oxford Endovascular are developing a novel treatment for treating brain aneurysms. The Oxford technology uses a special laser-cut metal alloy which has a shape-memory. It can be posted into a catheter during surgery, inserted into the brain and opened up into a tiny tube mesh (‘flow diverter’) that fits into the natural shape of the blood vessel.This diverts the blood away from the aneurysm, allowing it to heal.

Portfolio highlights

• Thioredoxin Systems — Thioredoxin Systems AB is developing an innovative antibiotic regimen for complicated urinary tract infections caused by antibiotic-resistant bacteria. The

Portfolio highlights

• Ludenso — Ludenso is a software developer of AR solutions for the education industry. To make education more creative and engaging, we are giving editors, authors, and teachers the power to bring their learning resources to life through 3D models, animations, videos, and audio support. This is made possible through the Ludenso Studio, where they can createinclusive learning experiences that enables students to learn in their own way.
• wheel.me — The first and only autonomous wheel in the world. The innovation transforms anything into an autonomous mobile robot with minimal effort and without the need to alter its design or form. The company was founded in 2013 and is headquartered in Oslo, Norway.
• Nofence — Nofence is a system virtual fencing for grazing animals. Virtual fencing of livestock has been a concept long discussed in academia. The Norwegian ag-tech startup Nofence has since 2011 developed and patented a solution for virtual fencing that has proven to work. The customers say that this will become a real gamechanger for livestock managementsince pastures can easily be defined by a few clicks on a tablet/smartphone. The herd is then safely fenced in and can be monitored. The system will send notifications if something happens. From the global food security perspective, this solution will make it much easier to utilize the uncultivated land for varied and healthy pasture, and make it possible to produce more food on cultivated land.

Portfolio highlights

• Combify — Combify is a PropTech company that works with simplifying the communication in city development projects.
• Natural Cycles — Natural Cycles birth control is 93% effective with typical use and 98% effective with perfect use. Learn more about hormone-free birth control today.
• Kyra — Kyra is a Gen-Z entertainment company creating engaging digital content that resonates with youth culture. We represent world class digital native talent, produce digital content with the biggest and best consumer brands and develop media properties publishing daily content on platforms that matter to Gen Z. Kyra has the ability to not onlytarget but truly engage with the Gen-Z audience through content that resonates based on real-time audience data from our proprietary KyraIQ technology. Our inclusive, ahead-of-the-trend content and content creators make us the ultimate destination for the Gen-Z consumer who wants to be inspired by their own community. Our approach and creativity is based on data and insights and has proven to engage this audience better than any traditional publisher. We house a talent agency representing and collaborating with the leading Gen Z social stars such as Abby Roberts and Noen Eubanks; a global content studio creating award-winning content for youth-seeking brand partners such as Converse and HP; and a newly developed portfolio of media properties publishing daily content on Gen Z-native platforms around beauty, fashion, adventure, food, gaming and entertainment.Kyra engages Gen Z better than any traditional publisher, with an audience of 78 million social media followers racking up 750 million monthly video views in 190 countries around the globe. We know exactly where Gen Z is spending their time online and we respect their interests and passions. That result is content that is meaningful and fosters long term engagement for blue chip brands. Our team are experts on Gen Z culture, whether they are producing, managing, creating or marketing in New York, London and Los Angeles. Learn more at https://kyra.com/reel

Portfolio highlights

• Sigrid Therapeutics — Sigrid Therapeutics is developing an ingested medical device for lowering blood sugar in prediabetics.

Portfolio highlights

• AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.

Portfolio highlights

• GLO — glō is a venture-backed company focused on the development and commercialization of advanced LED display products using nanotechnology. The unique nanotechnology is based on 11 years of research at Lund University’s Nanometer Structure Consortium. Headed by Professor Lars Samuelson, one of the world’s leading scientists in this field, who haspublished more than 500 papers related to this technology.glō's first office is in Lund, Sweden, where basic material research continues for the next generation nanotechnology. glō's research and product development along with pilot fabrication operation is carried out at glō-USA in Sunnyvale, California. In 2016, glō established an Asia office in Taipei, Taiwan, one of the largest and fastest-growing regions for LED lighting and display applications.glō's technology sidesteps the technical limitations of current planar LED technology. It allows for the creation of highly efficient, stable and ultimately unique red, green, blue (RGB) emitters out of one material system. It aims to achieve the industry’s best color stability and ultimately enables the growth of red, green and blue emitters on the same wafer. Highly-efficient white LEDs with high color rendering will be possible without the need for phosphor conversion. It is the next enabling technology for advanced display, illumination and automotive applications.glō nanowire light-emitting diodes (nLEDs) are based on its proprietary hetero-structured semiconductor nanowire epitaxial growth and process technologies for which standard manufacturing equipment and materials can be utilized.glō currently holds over 175 patents across US, Europe and Asia. These patents are not subject to any cross-licensing with the LED oligopoly. The glō team is constantly strengthening its intellectual property position in this technology and related applications.
• SantoSolve — SantoSolve is developing topical analgesic products based on non-radioactive strontium as the active substance. The Development program was initiated based on experimental clinical use of strontium-based products showing evidence of strong local analgesic effects on several localized pain conditions of both nociceptive and neuropatic origin. Nosignificant adverse effects associated with the treatment was reported.The company’s lead product, 2PX, is topically administered, utilizing dermal penetration enhancers for delivery of the active agent to its subdermal site of action. Phase I safety and pharmacology studies showed the active agent to have low systemic bioavailability, and only few and minor adverse effects were observed at the site of administration. In open label Phase II clinical trials, the product has shown strong analgesic effect in both nociceptive and neuropatic pain conditions. In follow up, placebo controlled trials, the analgesic effect of the product has been further documented. In the company’s most advanced pain indication under study, osteoarthritis, the company has recently completed the Phase II program.These trials supports the open label results and document statistically that the analgesic effect in patients treated with 2PX is superior to that observed with placebo treatment.
• Sol Voltaics — Founded in 2007, Sol Voltaics AB is a venture-backed, development-stage nanotechnology company focused on development and commercialization of highly efficient, third-generation photovoltaic concentrator solar cells based on its proprietary heterostructured nanowire epitaxial growth and process technologies.

Portfolio highlights

• Estmn — Estrid is an online portal that offers women's personal care products.
• Lassie — Lassie is the first proactive and preventive pet insurance company that wants to help pet owners take better care of their pets
• Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.

Portfolio highlights

• Nygen Analytics — Nygen empowers researchers to unlock insights from single-cell RNA-seq data with accessible, no-code solutions, facilitating reproducible transcriptomic research.

Portfolio highlights

• Thioredoxin Systems — Thioredoxin Systems AB is developing an innovative antibiotic regimen for complicated urinary tract infections caused by antibiotic-resistant bacteria. The

Portfolio highlights

• Cellfion — Cellfion provides sustainable materials for next level clean energy storage and conversion devices.​
• Ligna Energy — Ligna Energy is a green-tech start-up company developing disruptive technology and products for large-scale stationary electrical energy storage. The battery technology is made from cheap forest-based materials and organic polymers in combination with a water-based electrolyte. This is a unique solution foundation - enabling the world to shifttowards a fossil free energy system.

Portfolio highlights

• Q.ANT — Q.ANT develops photonic processors for AI and high-performance computing, utilizing light for information processing. The company also produces quantum sensors offering ultra-high magnetic field sensitivity in a compact form factor. These products aim to enable more intelligent and sustainable systems across various sectors like data centers,aerospace, and medical technology.
• Zuriq — We are building a quantum computer with scalability at its heart. Trapped-ion qubits with freedom to move and connect.
• Clock Bio — Clock Bio operates as a biotech company, that develops novel regenerative medicines.

Portfolio highlights

• Two — Buy Now, Pay Later for your business customers. Two makes it easy and safe to offer invoice as a payment method on your e-commerce site.
• Actithera — Actithera is a molecular radiotherapeutic company that develops radioligand therapies. It translates medicinal chemistry insights into new radioligand therapies (RLTs) and applies various molecular design strategies, including covalent targeting and an isotope-agnostic philosophy, to invent RLTs with significant differentiation and largertherapeutic windows.
• Kongsberg Ferrotech — Kongsberg Ferrotech offers game-changing robotic services for inspection, repair, and maintenance (IRM) of underwater installations

Portfolio highlights

• GlycoEra — GlycoEra is a CustomGlycan platform that unlocks the power of glycan-mediated biology to develop a pipeline of novel biologics.
• Affect — Get addiction and mental health treatment through an app that offers a full outpatient program, complete with medications and therapy.
• Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.